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Summary
We have characterized the amino acid sequences of over 20 endogenous peptides bound by a
soluble analog of H-2Dd, H-21)d Synthetic analogs corresponding to self, viral, tumor, or motif
peptides were then tested for their ability to bind to H-21)d by serologic epitope induction assays
using both purified soluble protein and cell surface H-21)d . The dominant primary sequence
motifincluded glycine at position 2, proline at position 3, and a hydrophobicCOOH terminus :
leucine, isoleucine, or phenylalanine at position 9 or 10 . Ancillary support for high affinity binding
was contributed by a positively charged residue at position 5 . Three-dimensional computer models
of H-2Dd/peptide complexes, based on the crystallographic structure of the human HLA-
B27/peptide complex, showed that the basic residue at position 5 was in position to form a
salt bridge with aspartic acid at position 156, a polymorphic residue of the H-21)d heavy (H)
chain. Analysis of 28 such models, including 17 based on nonamer self-peptides, revealed considerable
variation in the structure of the major histocompatibility complex (MHC) surrounding peptide
residue 1, depending on the size and charge of the side chain . Interactions between the side
chains of peptide residues 5 and 7, and 6 and 8 commonly occurred . Those peptide positions
with limited sequence variability and least solvent accessibility may satisfy structural requirements
for high affinity binding of the peptide to theMHC class IH chain, whereas the highly variable
positions ofthe peptide (such as positions 4, 6, and 8)may contributemore to theT cell epitopes.
T
he class IMHC encoded antigens are expressed at the
cell surface as ternary structures in which a 46-kD H
chain is noncovalently bound to both a small peptide frag-
ment 8-10 amino acids long and a 12-kD L chain, a2 -
microglobulin (S2m)l (1, 2) . The heterodimeric H/L chain
complexes bind to proteolytic fragments from the cell's en-
dogenous pool or to those resulting from infection with an
intracellular pathogen, or cellular dysregulation . At the cell
membrane this ternary complex can then interact with an
appropriateTCR to initiate activation . The crystal structures
of the humanMHC class I antigens HLA-A2 (3-5), HLA-
Aw68 (6), HLA-B27 (7, 8), and the murine H-2Kb (9-11)
reveal a molecular anatomy that reflects the function of these
molecules. TheH chain associates with the peptide in a groove
between the two helices of the al and 012 domains supported
by a floor of O-pleated sheet . Six pockets (termed A through
F) open onto the main peptide binding groove which can
accommodate peptide termini and amino acid side chains
having appropriate size, polarity, and charge (5, 6) .
t Abbreviations used in thispaper. 02m ; 02-microglobulin ; rms, root mean
square ; RU, resonance unit .
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The hallmark ofMHC class I molecules is their polymor-
phism, which dictates not only their ability to interact with
a variety of TCR, but their capacity to bind to a variety of
peptides with different primary sequences. The definition of
sequence motifs characteristic ofcertainMHC molecules has
been approached in several ways . Preferred amino acids at par-
ticular positions were determined by automated Edman degra-
dation of a pool of peptides that was isolated by acid elution
and reverse phase (RP) HPLC separation (2, 12, 13). Subse-
quently, individual or limited pools of peptides have been
identified by the sequencing of single HPLC fractions using
classical chemical, radiochemical, or mass spectrometry tech-
niques (14-17) .
A full understanding of the influence ofMHC polymor-
phism on both peptide and T cell interactions awaits the ac-
cumulation ofnot only a large data set of primary sequences
ofMHC molecules, but also a full library ofbound peptides
and structures of MHC/peptide complexes . Motifs of pep-
tides restricted to additionalMHC molecules should be elu-
cidated, as other molecules may use different polymorphic
regions in varying the repertoire of selected peptides . Like-
wise, more structures of peptide/MHC complexes need to
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acid sequence and the structural basis of antigen selection
by MHC class I molecules. One approach is to evaluate a
number of homogenous MHC/peptide structures crystal-
lographically. Another complementary and pragmatic ap-
proach is to identify a large number of cognate peptides for
many different class I molecules and to utilize modern ho-
mology modeling methods to describe the likely structures
of the MHC/peptide complexes . As part of our continuing
study ofMHC/peptide interactions, we present the charac-
terization of theH-213d peptide motif, the binding of a large
set of peptides, and the construction and analysis of three-
dimensional models derived from them . The H-2Ddpeptide
motif is unique, based on four amino acid residues, and reflects
several MHC amino acid sequence polymorphisms .
Materials and Methods
Protein and Synthetic Peptides.
￿
The soluble analog of H-2D',
H-2Dd, is a chimeric molecule expressed as the cxl, a2, and cx3 do-
mains of H-2D' with the 27 residues of theCOOH terminus of
Q106 (18, 19). Protein was immunoaffinity purified from transfec-
tant L cell culture supernatants on a column ofSepharose4B cou-
pled to the mAbs 34-5-8S, 34-4-20S, 34-1-2S, and 34-2-12S (20),
and concentrated by ultracentrifugation (Centricon 30 ; Amicon,
Beverly, MA) . Synthetic peptides (providedbyJ . Coligan, Biolog-
ical Resources Branch [BRB], National Institute of Allergy and
Infectious Diseases, Frederick, MD) were synthesized using stan-
dard Fmoc chemistry on peptide synthesizers and repurified by
RP-HPLC . Peptide purity was >90% . The peptides were dissolved
in dH20, except for those representing fraction 46 which were in-
soluble in water and were reconstituted in 20% DMSO.
Peptide Elution and Sequence Analysis.
￿
500 ICg purified H-2D,'
were brought to 0.1% TFA at ambient temperature and separated
by RP-HPLC using a Vydac C18 column (Separations Group,
Hesperia, CA) (4.6 x 250 mm, 5-AM particle size). The sample
was loaded in 0.1% TFA in dH20 (buffer A) for 15 min and then
eluted with a 0-60% linear gradient of 0.1% TFA in acetonitrile
(buffer B) over 60 min . After the gradient, the remaining material
was eluted for 10 min with 80% buffer B . The flow rate was
1 ml/min and the absorbance was monitored at both 215 and 280
nm . 1-ml fractions were collected, driedby vacuum centrifugation,
and recovered fractions30-53 were sequencedby automatedEdman
degradation on a sequenator (model 470A ; Applied Biosystems,
Inc., Foster City, CA) standardized to a repetitive yield of94% .
Residues were identified by amino acid analysis of a PTH analyzer
(model 120A ; Applied Biosystems, Inc.) . All sequencing andamino
acid analysis was performed by the BRB . Homologous sequences
were identified by searching the NationalBiomedical Research Foun-
dation (NBRF) data bank usingMaXector v.3.5 (IBI, NewHaven,
CT) and the nonredundant data bank at the National Library of
Medicine (Bethesda, MD) which includes : SWISS-PROT, PIR,
and GenPept using BLAST (21) .
Serological Detection Using Surface Plasmon Resonance
￿
Thebinding
of the a2 domain-specific mAb 34-5-8S (22) to various H-2Dd/
peptide complexeswas assessed by surfaceplasmon resonanceusing
the BIAcore"' (Pharmacia, Piscataway, NJ) . The carboxyl groups
ofthe carboxymethylated dextran matrix ofthe gold surfaceSensor
chipCM5TM (Pharmacia Biosensor AB) were chemically activated
during a 6-min continuous flow (5 IAl/min) exposure to a solution
of50 mM N-hydroxysuccinimide and 200mM N-ethyl-N'-(3-di-
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methylaminopropyl) carbodiimide hydrochloride, and then cova-
lently linked to the free amines of 34-5-8S (0.02 mg/ml in 10mM
NaAcetate, pH 4.5) for 6min . The remaining reactive groups were
then blocked with 1 M ethanolamine hydrochloride, pH 8.5 . To
enrich for H-2D1 molecules lacking preassociated peptides, protein
purified as described above was passed over a 34-5-8S coupled
Sepharose 4B column and the flowthrough was concentrated by
Centricon 30 ultracentrifugation . 50 ICI of 10 ICg/ml 34-5-8S-
depleted H-2Dd protein was added to 50 ICI of varying amounts
of peptide in 10 mM Hepes (pH 7.5), 150 mM NaCl, 3.4 mM
EDTA, 0.05% Tween 20 (HBS) or HBS alone at room tempera-
ture to achieve equilibrium (at least 15 h) . 30 Al aliquots were ana-
lyzed for direct binding to theimmmobilized 34-5-8S on the ma-
trix surface by plasmon resonance . The flow rate was constant at
5 Icl/min and the Ab surface was regenerated with a 1-min wash
of 5mM phosphoric acid . Control experiments indicated that high
concentrations (>200 ICM) of free peptide failed to bind the Ab-
coupled surface. 1,000 resonance units (RU) correspond to a sur-
face concentration of -1 ng/mm2 .
Serological Detection Using Immunofluorescence and Flow Cytom-
etry . LKD8 cells express low cell surface levels of H-2D' at 37°C
butcan be stabilized in their expression of class I molecules in the
presence ofexogenous peptide (23, 24) . These cells were propagated
inDMEM supplemented with 10% FCS, 2mM glutamine, nones-
sential amino acids, 50 ICg/ml gentamicin, and 5 x 101M2-ME .
The cells were washed withDMEM 10% FCS after trypsinization
and a second time with medium lacking serum . Cells (106 per well
in 24-well plate [Costar Corp., Cambridge, MA]) were incubated
overnight at 37°C in the presence of graded amounts of synthetic
peptide and 2 ICg/ml human I82m (Calbiochem, San Diego, CA)
in NCTC-109 (GIBCO BRL, Gaithersburg, MD)containing 0.5%
BSA . The cells were stained with 34-5-8S (2.7 ICg/ml in DMEM)
followed by FITC-conjugated goat F(ab')2 anti-mouse Ig (Cappel
Laboratories, Organon Teknika, Durham, NC) on ice . Propidium
iodide was added, and viable cells were analyzed on a FACScana
(Becton Dickinson &Co ., Mountain View, CA) .
Analysis ofSequence Variability.
￿
Peptide sequences were analyzed
for sequence variability according to the algorithm ofWu andKabat
(25) and for structural variability according to Padlan (26) using
the amino acid dissimilarity values ofGrantham (27), as described
previously (17) .
MolecularModeling.
￿
Three-dimensional coordinates for theHLA
B27/peptide complex based the 2.1 A crystal were kindly pro-
videdbyD. Madden andD . Wiley (Harvard University, Cambridge,
MA) (8). The amino acid structures corresponding to the H-2Dd
sequence for residues 1 to 276, and for murine 02m (28, 29)were
substituted at the positions of the corresponding residues in
the HLA-B27 structure using the computer graphics program
QUANTA 3.3 (Molecular Simulations, Inc., Hudson, MA) im-
plementedon a work station(INDIGO; Silicon Graphics, Moun-
tain View, CA). The alpha carbons, Ca, of the substituted amino
acids were superimposed on those of the corresponding residues
of HLA-B27andthe side chains were maximally overlapped . HLA-
B27 and H-2D1 have 74% sequence identity over the 276 amino
acid residues for which three-dimensional structure is available . There
wasno need to introduce gaps in either sequence to maximize the
homology alignment . Similarly, antigenic peptide residues were
substituted onto the corresponding positions oftheHLAB27bound
peptide. Prolines were substituted without difficulty in the trans
configuration in all cases. After the substitution, the amino acid
side chains were regularized to eliminate geometric incompatibili-
ties, and the resulting coordinates were subjected first to 100 steps
ofminimization using theAdopted Basis Newton Raphsonmethodin QUANTA (30) . Using X-PLOR 3.0 (31) these structures were
subjected to simulated annealing (32, 33) by heating to 1,000°K
and slow cooling to 300°K . The final cooled structure was sub-
jected to 120 steps of minimization by the method of Powell (34)
usingX-PLOR . The only constraints invoked in the simulated an-
nealing were the disulfide bonds joining residues 101 to 164 and
203 to 259 of the H chain and residues 25 to 80 of the (02m L
chain . Final coordinates for each structure were compared for root
mean square (rms) deviations, molecular surface exposure, and
atomic contacts . Connolly surfaces (35) were calculated for a water
probe of 1.7 A radius . The validity of the simulated annealing
procedure in building these models is emphasized by the demon-
stration that a model of theHLA-A2 molecule built by the same
procedure compared favorably to the crystal structure ofHLA-A2
with rms deviation of all 276 Ca atoms of <1.5 A. Atomic coor-
dinates for the models described here will be made available on
request .
Results
Identification of the Sequence Motffor H-2Dd Bound Pep-
tides . Our laboratory has previously investigated the stimu-
lation of both alloreactive and peptide-specific T cells using
purified preparations of a secreted soluble analog ofH-2Dd
(19, 36, 37) . As a step in the detailed characterization of the
molecular structures recognized by H-2Dd-restricted T cells,
we analyzed the peptides that copurify through immuno-
affinity isolation with H-2Dd. Approximately half a milli-
gram of soluble molecules, purified from transfected L cell
supernatants as described in Materials and Methods, was dena-
tured with TFA and separated by RP-HPLC (Fig. 1) . Frac-
tions containing small pools of peptides were collected and
sequenced by automated Edman degradation (Table 1) . The
sequences were typically 9 or 10 amino acids in length, con-
sistent with the findings of several other studies evaluating
MHC class I/bound peptides from detergent extracts ofcells
(2, 16, 38-41), or from engineered soluble H-2Ld (17) .
Although two fractions (30 and 31) yielded no sequence,
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Figure 1 .
￿
RP-HPLC profile of H-2Dd, molecules. H-2W, molecules
were immunoafftnity purified, denaturedwith 0.1%TFA, andloaded onto
a C18RP-HPLC column as described in Materials and Methods. Peptides
were then eluted with a 0-60% linear acetonitrile gradient between 15
and 75 min . The region ofpeptide elution is magnified in the inset (bottom,
blank injection ; top, H-2Dd,/peptide separation) . Absorbance shown is at
215 nm.
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and the repetitive yields from fraction 32 suggested that its
sequence was incomplete, reliable data were obtained from
fractions 33-53 . On inspection, nearly all peptide sequences
contained glycine at position 2, proline at position 3, and
a hydrophobic residue (leucine, isoleucine, or phenylalanine)
at theCOOH terminus. An additional conserved residue was
frequently identified at position 5 where positively charged
arginine or lysine predominated . (In fraction 49, the basic
residue was identified at position 6, after glycine) . This
H-2Dd motif (glycine at position 2, proline at position 3,
positively charged residue at position 5, and a hydrophobic
COOH-terminal residue) was also present in two previously
described H-2Dd restricted peptides : the HIV-IIIB envelope
glycoprotein p18-I-10 (42) and the turn- P35B peptide (43,
44) (Table 1) .
To identify possible sources for the copurified peptides, sev-
eral databases were scanned for homologous sequences, as de-
scribed in Materials and Methods . The best protein matches
and fractions ofhomology are indicated in Table 1 . Although
no perfect matches to known proteins were made, the search
detected proteins derived from a wide variety of cellular com-
partments . Homology to serum-derived proteins was not ob-
served, consistent with the view that the copurified peptides
derive from the cell that synthesizes the MHC molecule.
Synthetic analogs were prepared based on the sequences
of those peptides that were eluted from H-2D, (Table 2) . In
cases in which the amino acid assignment could not be made
with certainty, an alanine residue was incorporated at those
positions, except for alternate COOH-terminal residues in
which case a leucine or isoleucine was preferred . For some
of the sequenced peptides there were two possible terminal
residues at positions 9 and 10, either of which was consistent
with the motif . In those cases both the decamer and the
nonamer truncation weremade. In our peptide binding studies,
we also used the originally described H-2Dd-restricted quin-
decamer peptide from the HIV-IIIB gp120 glycoprotein
RIQRGPGRAFVTIGK (p18) (45), and the optimal decamer
RGPGRAFVTI (p18-1-10), as well as the undecamer tum -
H-2Dd-restricted peptide NGPPHSNNFGY (turn - P35B)
(43), and a nonamer truncation that would conform to the
elucidated motifNGPPHSNNF (turn- P35B-F9) . To eval-
uate the effect of the anchor residues, four motif peptides
were analyzed : AGPAAAAAL (pD239), AGPARAAAL
(pD2359), GPGGGGGGL (pL29G), andGPPPPPPL (pL28P) .
The length of the different spacing elements in the motif
peptides was based in part on the previous findings of Mary-
anski et al . (46), who demonstrated that a proline spacer one
residue shorter than expected was the most effective in gener-
ating a motif peptide for binding to H-2Kd .
Each of the synthetic peptides was analyzed byRP-HPLC
as well, to confirm that it was representative of the sequenced
peptides. Of the synthetic peptides, pD36, pD38A, pD39,
pD40, pD41, pD44, pD45, pD47, pD48A and B, andpD53B
had the same retention times as those fractions from which
their sequences were obtained . The synthetic self-peptides,
which had alanine inserted for uncharacterized residues, did
not have the same retention time as the original sequencedThe material in recovered HPLC fractions 30-53 was sequenced by automatedEdman degradation . The typeface classifications for amino acids report-
ed include: boldface for a unique residue, plain uppercase for a quantitatively dominant residue, and plain lowercase for a residue with the least assur-
ance due to low quantity or heterogeneity at that position . Positions for which an assignment could not be confidently made are designated with
an X. Homologous proteins were identified by searching multiple data banks as described in Materials andMethods and are followed by the fraction
of exact amino acid matches with the identified residues in the sequenced fraction . Accession numbers for best matches were : fraction 32, A25440
(62) ; fraction 33, S10892 (63) ; fraction 34, J05149 (64) ; fraction 35, A03845 (65) ; fraction 36, A34549 (66) ; fraction 37, M83312 (67) ; fraction
38, X02761 (68) ; fraction 39, M82858 (69) ; and fraction 40, M26434 (70) ; fraction 41, M65260 (71) ; fraction 42, B26186 (72) ; fraction 43, X15610
(73) ; fraction 44, A24028 (74) ; fraction 45, M77183 (75) ; fraction 46, A00515 (76) ; fraction 47, M61648 (77) ; fraction 48, S74678 (78) ; fraction
49, M28821 (79) ; fraction 50, A24300 (80) ; fraction 51, Z11922 (81) ; fraction 52, S18620 (82) ; and fraction 53, M20982 (83) .
fraction, suggesting that other amino acids were at these po-
sitions, possibly cysteine residues which cannot be identified
by this sequencing technique .
Synthetic Peptides Induce Reactivity with an Epitope-specfic
mAh As we had characterized sequences which putatively
represented peptides from denatured H-2Dd molecules, we
wished to confirm their ability to bind to H-2Dd. In this
studywe used an indirect assay to evaluate this binding: the
addition of exogenous synthetic peptide to H-2Dd to induce
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the formation of the 34-5-8S epitope, which is specific for
the H-2Dd a2 domain and conformationally dependent on
the presence of bound peptide (23, 47) . A population of
H-2Dd molecules that was relatively free from preassociated
peptides (prepared as described in Materials and Methods)
was incubatedwith titrated amounts of synthetic peptide in
solution and then assayed for the ability to bind to immobi-
lized 34-5-8SAb on a solidphaseby real time surface plasmon
resonance . RU are directly proportional to the amount of
Table 1 . Sequences of Eluted Self-peptides
Sequence
Fraction 1 2 3 4 5 6 7 8 9 10 Homology
30 No sequence
31 No sequence
32 s E Q D L N f Elongation factor rat (6/7)
33 s X H K E Q P A T Transforming protein spi-1 human (7/8)
34 s X P K T D X Q T L Insulin receptor precursor murine (7/8)
35 K G P I T V Q I Fiber protein adenovirus2 (6/8)
36 V G P Q K N E N L Transferrin receptor rat (6/9)
37 s G P R K X I X L mRNA CD40 mouse (6/7)
38 a G P D R T E K X L Fibronectin precursor human (6/9)
39 k G P D K G N E F Metalloproteinase 2 inhibitor mouse (7/9)
40 i G P E R G H N L Hypoxanthine phosphoribosyltransferase human (7/9)
41 D G P V R E H N L Urease Canavalia ensiformis (7/9)
42 K G P E R X N G L Pyruvate kinase rat (6/9)
43 s G P E R G E K L Proliferating cell nucleolar antigen P40 human (7/9)
44 D G P V R G I S I Ribosomal protein S17 rat (8/9)
45 N G P Q R I Y N L Alpha 1 macroglobulin rat (6/9)
46 s G P v a L V N F I Superoxide dismutase horse (6/10)
47 I G P N R a f N F HIV 1 envelope protein (6/9)
48 S G P E R I L S X Y Heterogeneous nuclear ribonucleoprotein complexK (8/9)
49 V G P S G K y F I L T complex associated testes peptide mouse (7/10)
50 F G P y k L N R L Feline leukemia virus envelope polyprotein (8/9)
51 F G P I K F n V L T Ran Canis familiaris (7/10)
52 A G P d R f I X X M Amidotransferase II Streptomyces griseus (6/8)
53 F G P y R F Y V L T LasA protein Pseudomonas aeruginosa (7/10)
Known H-2131-restricted antigens
N G P P H S N N F G Y tum-P35B
R G P G R A F V T I p18-1-10Table 2 .
￿
Sequences of Synthetic Sefpeptides
Sequence
Name
￿
1 2 3 4 5 6 7 8 9 10
G I
Y
Apanel of synthetic peptides was patterned after the sequences identified
for the acid-eluted H-2Da self-peptides with alanine residues inserted at
positions where the sequences was not clearly defined . Each synthetic
peptide is designated by the HPLC fraction from which the sequnce was
originally identified . Peptides pD239, pD2359, pL29G, and pL28P, each
of which contain elements of the H-2Dd peptide motif, separated by
repetive single residue spacers, were also synthesized .
mass bound, and this assay provides results that are similar
to those of a conventional ELISA . These results are plotted
in Fig. 2, A-H . All nonamer peptides tested, the octamer
pD35 (Fig. 2 G), several decamers (p18-I-10, all panels ; pD38B,
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Fig . 2 C ; pD49B, Fig. 2 D ; pD48C, Fig. 2 E ; pD34, Fig .
2 G ; pD53B, andpD46A, Fig. 2 F), and the turn -P35B un-
decamer (Fig . 2 A) effectively induced the 34-5-8S epitope.
Two motif nonamer peptides were also examined, pD239
(containing motif residues at positions, 2, 3, and 9) and
pD2359 (containing arginine additionally at position 5) (Fig .
2 B) . The motifpeptide with arginine at position 5 (pD2359)
induced the 34-5-8S epitope more effectively than the motif
peptide with alanine at that position (pD239), suggesting
that the positively charged residue at position 5 contributed
to the interaction with the H chain . The only endogenous
peptide sequence with an alanine at position 5 was fraction
46 . Two peptide analogs representing this sequence were made,
a nonamer and a decamer, both of which required an organic
solvent for solubilization . The requirement for greater ap-
parent concentrations of these peptides to induce the epitope
(Fig. 2 F) most likely represented the relative insolubility of
these peptides in aqueous solution, masking their true affinity
for H-2Da. Both peptides which had threonine at position
5, pD34 and pD35, efficiently induced the 34-5-8S epitope.
Different peptides were made representing other fractions
that had multiple possible overlapping COOH-terminal
residues : fractions 38, 48, 49, and 53 . In each case the nona-
meric peptides had higher apparent binding affinities for the
H chain than the related decamers, but both peptides from
each set were able to bind . Thus, all the synthetic peptides
corresponding to the endogenous peptide sequences bound
H-2Da, as measured by this epitope induction assay. In the
case of the previously described H-2Da-restricted peptide
turn - P35B (Fig . 2 A), the undecamer peptide weakly in-
duced the epitope with a halfmaximal point abouttwo orders
of magnitude less than the nonamer truncation that termi-
nated in phenylalanine. Similarly, the P18 quindecamer did
not induce the epitope, but the nested decamer accomplished
this readily (Fig . 2 C) . Thus, all the synthetic peptides corre-
sponding to the endogenous peptide sequences bound
H-2Da, as measured by this epitope induction assay .
To demonstrate that the binding of these endogenous pep-
tide analogs to H-213d was not unique to the soluble protein
system, we evaluated their ability to bind to membrane-
associated molecules. We used an H-213d-transfected em-
bryonic cell line, LKD8, which expresses low levels of
H-2Dd at 37°C (23) . Surface expression of H-2Dd on this
cell line can be stabilized by the addition o£ exogenous cog-
nate peptides in the presence of a2m, as the cells have an in-
herent defect in efficiently providing peptides to nascent class
I proteins before their transit to the cell membrane (24) . The
cells were incubated with synthetic peptides (see Materials
and Methods) and then assayed for the presence of 34-5-8S
epitope by flow cytometry (see Fig . 3) .
Fig . 3 A depicts representative examples of fluorescence
histograms with increasing peptide concentrations in the fore-
ground . In rank order, the most effective peptide in inducing
the 34-5-8S epitope was P18-I-10 followed by the nonamer
truncated turn - P35B-F9, pD2359, pD39, pD239, and
turn- P35B. The results of the analysis of all the peptides
are plotted in Fig . 3B. As with the epitope induction assay
employing purified H-2Da protein described above, the poor
pD34 SG PKT DAQT L
pD35 K G P I T V Q I
pD36 VGPQKNENL
pD37 SGPRKA I AL
pD38A AGPDRTEKL
pD38B AG PDRTEKA L
pD39 KGPDKGNEF
pD40 I GPERGHNL
pD41 DGPVREHNL
pD42 KGPERANG L
pD43 SGPERGEKL
pD44 DGPVRG I S I
pD45 NGPQR I YN L
pD46A SGPVALVNF I
pD46B SGPVALVNF
pD47 I GPNRAFNF
pD48A S G P E R I L S I
pD48B SGPER I LSL
pD48C SGPER I LSA Y
pD49A VGPSGKYF I
pD49B VGPSGKYF I L
pD50 FGPYKLNRL
pD51 FGP I KFNVL
pD53A FGPYRFYVL
pD53B FGPYRFYVL T
pD2359 AG PARAAAL
pD239 AG PAAAAAL
pD29G G PGGGGGG L
pL28P GPPPPPPL
p18 R I QRG PGRAFVT I
p18-I-10 RG PGRAFVT I
turn - 35B NGPPHSNNF G
turn- 35B-F9 NGPPHSNNFA
ftum35B-9 NGPPHSNNF
￿
375
-atum35B NGPPHSNNFGY
1Ep18-I10 RGPGRAFVTI
￿
250
-,~rPD38B AGPDRTEKAL
*PD38A AGPDRTEKL
￿
Up00 {}PD36 VGPQKNENL
fp18-I10 RGPGRAFVTI
-X-p18 RIQRGPGRAFVTIGI0100
E
-*PD48A SGPERILSI
QPD48B SGPERILSL
;PD48C SGPERILSAY
fp18-I10 RGPGRAFVTI
G
-f-PD34 SGPKTDAQTL
-E-PD35 KGPITVQI
-ffPD41 DGPVREHNL
fpD43 SGPERGEKL
QPD45 NGPQRIYNL
fp18-I10 RGPRAFVTI
0
140 a
N 70
.~ E 0
Z300
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B
$pD239 AGPAAAAAL
pD2359 AGPARAAAL
fp18-110 RGPGRAFVTI
D
epitope stabilization by the peptidespD46A andB may reflect
their relative aqueous insolubility and not their true ability
to associate with the class I chain . In all other cases in which
nonamers were compared to decamers of the same fraction,
the nonameric peptide was more effective at preserving the
epitope than the decamric peptide (pD38, pD48, pD49, and
pD53) . Nevertheless, the p18-I-10 decamer was the most effec-
tive peptide studied .
Figure 3 .
￿
Peptides stabilize the 012 domain conformationally sensitive
34-5-8S epitope on H-2Dd-expressing embryonic cells. LKD8 cells were
incubated in serum-free medium in the presence of titrated amounts of
peptide (2.5, 0.25, and 0.025 PM) and human 0 2m overnight and then
analyzed for reactivity to 34-5-8S by indirect immunofluorescence. (A)
The induction of the 34-5-8S epitope with pD239 and pD2359, p18, p18-
1-10, turn- P35B, and turn- P35B-9 with histogram plots. (B) Summary
plot of mean fluorescence by peptide vs peptide concentration for all pep-
tides tested .
-+pD47 IGPNRAFNF
*PD49B VGPSGKYFIL
OPD49A VGPSGKYFI
-A,pD50 FGPYKLNRL
-&PD51 FGPIKFNVL
fp18-110 RGPGRAFVTI
F
-aPD53A FGPYRFYVL
OpD53B FGPYRFYVLT
fp18-I10 RGPGRAFVTI
-{-pD46A SGPVALVNFI
+pD46B SGPVALVNF
H
->(-pD37 SGPRKAIAL
--pD39 KGPDKGNEF
A-PD40 IGPERGHNL I
'apD42 KGPERANGL
10-3 10 -1 10 1 10-3 10 -1 ￿10 1 103 OpD44 DGPVRGISI
Peptide Concentration (~M)
￿
fp18-I10 RGPGRAFVTI
Figure 2 . Peptides generate the a2 domain
conformationally sensitive 34-5-8S epitope on
H-213d, molecules . Varying concentrations of syn-
thetic peptides as indicated were added in solution
to purified H-2Dd. The subsequent reactivity to
the immobilized Ab, 34-5-8S, was assayed using
real time plasmon surface resonance as described
in Materials and Methods . NormalizedRU repre-
sent the difference inRU in the presence and ab-
sence of added peptide. Under these conditions,
free p18-1-10 or pD2359 at concentrations as high
as 222 uM gave a signal of <7 RU.
The synthetic peptides induced the expression of H-2Dd
to varying degrees with the exception of the polyglycine-
substituted motif peptide (pL29G), which did not stabilize
the epitope at all (Fig. 3 B) . Ofthe motifpeptides, the alanine-
substituted spacing residues were apparently better than the
proline or glycine residues at supporting binding by the an-
chor residues (compare p239, pD2359, pL29G, and pL28P) .
The most effective motif peptide at stabilizing the 34-5-8S
epitope waspD2359 with an arginine at position 5, suggesting
that although the positive charge is not essential for peptide
binding, it promotes a stronger interaction with theH chain .
Qualitatively, the cell surface epitope induction assay was in
agreement with the assay using soluble, purified H-2Dd.
Sequence and Structural Variability.
￿
Although inspection of
the sequences of the endogenous peptides suggested that the
gly-pro sequence at residues 2 and 3 and the hydrophobic
residue at theCOOH terminus were conserved,we also elected
to evaluate the sequences obtained by objective sequence and
structural variability criteria . The eluted peptides that were
demonstrated to be capable of binding to H-2Dd were
grouped into decamers and nonamers . Omitting unassigned
residues, these sequences were then analyzed for sequence and
structural variability (Fig . 4) (25, 26) . Since the Wu/Kabat
(25) sequence variability provided an indication ofhow many
different amino acids were observed at a given position rela-
tive to the frequency ofthe mostcommon amino acid at that
position, this calculation treated both conservative and rad-
ical substitutions equivalently. The structural variability al-
gorithm imposed a bias dependent on the degree of chemical
dissimilarity ofthe observed substitutions . The sequence and
structural variabilities correlated well for the nonameric se-
quences : pD36, pD37, pD39, pD40, pD41, pD42, pD43,
pD44, pD45, pD47, pD50, and pD51 . Notably, positions
2, 3, 5, and 9 were most restricted in the observed variability,
and the most varied residue was at position 1 (Fig. 4,A and
C) . Fewer decamer sequences were available for this analysis :
pD38, pD46, pD48, pD49, pD53, and p18-I-10 . Both the
sequence and structural variabilities were limited at positionsFigure 4. Sequence and structural variability of 12 nonamer and 6
decamer H-213d-binding peptides. Nonamer sequences of peptides pD36,
pD37, pD39, pD40, pD41, pD42, pD43, pD44, pD45, pD47, pD50, and
pD51 were compared according to the methods of Wu and Kabat (25)
(A), and Padlan (26) (C, as were decamer sequences of peptides pD38,
pD46, pD48, pD49, pD53, and p18-1-10 (B and D, respectively) . The
fractional accessibility of each amino acid residue, defined as the amount
ofsurface area that is accessible to a solvent probe in the three-dimensional
structure divided by the surface area that would be exposed if the residue
(X) were in an isolated Gly-X-Gly tripeptide with the same backbone
configuration as the corresponding tripeptide in the structure, was com-
puted according to Padlan (61) (E) . Deviation of the Ca position from
the average was calculated (F) .
2, 3, and 10 (Fig . 4, B and D) . There appeared to be less
biochemical restriction at position 5 than in the nonameric
sequences, which may represent flexibility in the middle of
bound peptides, allowing the binding cleft to accommodate
longer peptides .
Construction and Analysts ofMolecular Models ofH-2Da/Pep-
tide Complexes . To examine the structural basis of the inter-
action of the H-2Dd molecule with self, viral, and tumor-
specific peptides, we built three-dimensional models of the
H-2Dd/peptide complexes based on the x-ray crystallo-
graphic structure ofthehumanMHC class I molecule HLA-
B27/peptide complex (7) . The atomic coordinates ofthis struc-
ture provided a template for modeling nonamer peptides with
motifs suggestive of interactions in the B and F pockets of
the binding groove, since HLA-1327 revealed anchors at pep-
tide positions 2 and 9. Molecular models were constructed
for 17 nonamer self-peptides, the truncated peptide turn -
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P35B-F9, and two motif peptides pD239 (AGPAAAAAL)
and pD2359 (AGPARAAAL) .
After the modeling routine described in Materials and
Methods, which omits water, the resulting structures were
examined for contacts between the bound peptide and the
H chain, as well as the surface areas of both the peptide and
MHC that were buried on binding (Table 3) . Individual self-
peptides had buried surface areas from 534 to 733 A2 with
a mean of 655 A2 , and the corresponding H-2Dd surface bu-
ried was from 740 to 1024 A2 with a mean of 917 A2 . Pep-
tides made extensive contacts with the class I molecule : an
average of about 162 van der Waals contacts with a range
of 134 to 208, an average of 21 hydrogen bonds (range 15
to 29), and from 1 to 7 ion pairs (salt bridges) . Notably,
pD239, the minimal motif peptide, had the lowest values
for buried surface, and the fewest van der Waals contacts,
hydrogen bonds, and salt bridges. The cx-amino group ofthe
first peptide residue and the carboxylate group ofthe000H-
terminal residue were frequently involved in salt bridges . There
was no simple correlation between either the amount of sur-
face area buried or the number or kinds of contacts and the
apparent strength of binding to H-213d as assessed by the
epitope induction assays employed .
Side chains at each of the nine peptide positions in the 17
nonamer H-213d-binding self-peptides were compared for
their rms deviation from the average position and for the av-
erage fractional accessibility to solvent (Fig. 4, E and F) . Po-
sitions 1, 2, and 9 had very little if any accessibility to solvent
and amino acids at positions 4, 6, and 8 had the greatest (Fig.
4 E) . Rms deviation from average position was smallest for
positions 1, 8, and 9, and greatest for positions 2, 3, 6, and
7 . Side chain/side chain interactions of nonadjacent amino
acids were quantitated for the 17 models of the H-213d
bound nonamer self-peptides . Between positions 5 and 7, 67
interactions were counted, and between residues 6 and 8, 11
interactions were counted . In addition, residues 7 and 9 had
four interactions, and residue 5 interacted with residue 3 or
4 once.
Similar to published crystallographic structures, the pep-
tide lies in an extended conformation with the NH2 and
COOH termini anchored at the left and right sides of the
peptide binding cleft (Fig. 5, A and B) . Our modeling sug-
gests that the molecular architecture surrounding the NH2
terminus of the peptide is determined in large part by the
chemical character of the amino acid side chain at position
1 . It is proposed, for example, that in the A pocket the
NH2-terminal amine of pD43 (SGPERGEKL) hydrogen
bonds to Y7 and Y59 of H-2Dd and the hydroxyl of the
serine side chain hydrogen bonds to Y171 (Fig . 6A) . In con-
trast, as shown in Fig. 6 B, the amine of the acidic aspartate
of peptide pD41 (DGPVREHNL) would be in position to
hydrogen bond to E63 and Y171 and the carboxylic acid side
chain forms salt bridges with R62 and R66 . Alternatively,
the amine ofpD42 (KGPERANGL) would hydrogen bond
to Y7, Y45, and Y59, but cannot directly interact with Y171
(Fig . 6 C) . The NH2-terminal lysine forms a salt bridge
with the side chain ofE163 and hydrogen bonds to the back-
bone carbonyl oxygen of E163 as well (data not shown) . The1884
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￿
H-2D'/Peptide Interactions
larger side chain ofarginine at position 1 of the viral peptide,
p18-I-10, is accessible to solvent and also interacts with E163
(Fig. 6 D) . In this case the NH2-terminal amine hydrogen
bonds with Y59 . Comparison of Fig. 6, C andD indicates
the kind of adjustments that residues Y7, Y171, R62, and
R66 can make even when the conserved substitution of ly-
sine to arginine at position 1 of the peptide occurs.
To illustrate other interactions observed between the bound
peptide and MHC, as well as between peptide side chains,
we will describe the model of the pD43/H-2Dd complex in
some detail . We observe that conserved glycine and proline,
representing residues 2 and 3, are constrained beneath the
canopy formed by residues R62, R66, and E163 which form
a salt bridge between the al and a2 helices (Fig. 6 A) . These
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Molecular surface lost on peptide binding was calculated for the indicated peptide/MHC models using the Connolly algorithm (35) .
t Two atoms are said to be in van der Waals contact if they are within the sum of their van der Waal's radii plus 0.5 A of each other .
S Two atoms are said to be hydrogen bonded if they are within 2.9 ± 0.5 A of each other .
11 Two oppositely charged atoms are said to form an ion pair if they are within 2.85 ± 0.5 A of each other.
two peptide residues interact primarily with R66 . Residue
4, a glutamic acid, is directed toward solvent and interacts
with R66 from above through 21 atomic contacts. Residue
5, in this case the basic arginine, is oriented toward the D
pocket (5, 6) under the a2 helix, and is also inclined par-
allel to the peptide backbone toward the COOH terminus
through interactions not only with aspartate 156, but also
with the glutamate at position 7 of the peptide (Fig. 6 E) .
Peptide residues 6 and 8 point away from the cleft and are
close enough to hydrogen bond with each other . TheCOOH
terminus is anchored in the F pocket through hydrogen
bonding ofthe penultimate carbonyl with the invariant W147 ;
hydrophobic interactions of the COOH-terminal leucine side
chain with residues A81 (data not shown), L95, F116, Y118,
Figure 5.
￿
Molecular model of the H-2Dd/pD43 complex . A van der Waals space filling model of the pD43 peptide is shown in lateral (fl) and
coronal (B) views, displaced from the corresponding calculated molecular surface representation of the H-2Dd residues that line the binding pocket.
Colors represent polarity of the amino acid side chains : red, acidic; blue, basic ; yellow, polar, noncharged; and light blue, nonpolar . The approximate
locations of the pockets analogous to those described by Saper (5) and Garrett (6) are indicated by letters A through F .
Ligand Sequence
Peptide
surface
buried (Az)
H-21)d
Surface
buried (AZ)
van der
Waals
contacts
Number of
Hydrogen
bonds Ion pairs
pD36 VGPQKNENL 662' 939" 160# 23S 311
pD37 SGPRKA I AL 630 868 152 21 3
pD38 AGPDRTEKL 632 944 134 23 5
pD39 KGPDKGNEF 654 955 163 24 7
pD40 I GPERGHNL 683 1024 177 25 6
pD41 DGPVREHNL 665 940 145 21 6
pD42 KGPERANGL 638 924 152 26 6
pD43 SGPERGEKL 664 937 185 29 5
pD44 DGPVRG I S I 625 872 129 23 4
pD45 NGPQR I YNL 678 812 199 27 3
pD46 SGPVALVNF 534 740 122 17 1
pD47 IGPNRAFNF 733 977 194 19 3
pD48 SGPER I LS I 603 858 150 23 5
pD49 VGPSGKYF I 646 824 144 17 1
pD50 FGPYKLNRL 673 957 169 17 2
pD51 FGP I KFNVL 688 1030 176 14 3
pD53 FGPYRFYVL 730 992 208 15 3
pD239 AGPAAAAAL 547 693 120 11 1
pD2359 AGPARAAAL 615 886 163 22 3
tum-35B-F9 NGPPHSNNF 656 1003 145 18 3Y123, and 1124 ; a hydrogen bond between the carboxylate
terminus and T143 ; and a salt bridge formed with K146
(Fig . 6 F) .
In addition to the set of nonamer peptide/H-2Dd models,
we built models of one octamer (pD35, KGPITVQI) and
six decamer peptide/H-2Dd complexes. The resulting model
of the pD35/H-2Dd complex maintained the side chain of
the COOH-terminal residue in the F pocket, and had the
side chain ofthe threonine at position 5 oriented for hydrogen
bonding to D156 . To preserve the architecture revealed by
the X-Gly-Pro-X-(Arg, Lys)-X-X-X-(Leu, Ile) motif, five al-
ternate models were constructed for each decamer peptide
by introducing the additional residue after position 5, 6, 7,
8, or 9 . After the minimization/slow cooling procedure de-
scribed in Materials and Methods, the decamer models with
insertions after residue 5, 6, or 7 resulted in structures with
similar backbone configurations and side chain orientations,
whereas addition after position 8 or 9 resulted considerable
distortion of the modelled structures . Also, these structures
frequently showed side chain/side chain interactions ofresidues
5 with 7, and 6 with 8 as did the nonamer structures. A
direct comparsion of the peptide structures of the octamer
pD35, nonamer pD43, and decamer p18-I-10, is displayed
in Fig. 7 . The backbone configuration dictated by the pro-
line at position 3, as well as the interaction of peptide residue
5 with D156, the anchoring of the hydrophobicCOOH ter-
minus and the side chain/side chain interactions permits these
peptides of different length to bebound by the same MHC
molecule .
Discussion
In the past several years, beginning with the seminal ob-
servations of Falk et al . (48) and van Bleek and Nathenson
(14), it has become apparent that both endogenous and viral
peptides associated with MHC class I molecules can be
identified and sequenced . Such studies provided the basis for
a structural understanding of the interaction of particular
MHC class I molecules with particular peptides . Here we
have described a largenumber ofpeptides that were copurified
with a soluble analog of H-2Dd, studied their binding by
induction of a serologic epitope, and analyzed their struc-
tural interaction with the class I H chain using computer-
generated molecular modelsbased on the crystallographic coor-
dinates of the HLA-B27/peptide complex . This analysis not
only permitted the determination of the binding motif for
H-2Dd restricted peptides, but also an evaluation of the pep-
tide/MHC and intrapeptide interactions that contributed to
a stable ternary complex.
The peptides that copurified with the H-2Dd soluble ana-
log likely represented the more tightlybound subset of pep-
tides, having been selected by the protein production and im-
munopurification procedures . Those peptides identified were
predominately nonamers and decamers, however one octamer
was confidently identified . The length of these peptides was
consistent with the findings of others who have character-
ized MHC class I-associated peptides . However, unlike the
previously described peptide motifs involving two residues,
the amino acid composition of the H-2Dd peptides was re-
stricted at four positions : glycine at 2, proline at 3, basic res-
idue at 5, and hydrophobic residue at the COOH terminus .
The motif was confirmed with the epitope induction due
to the peptides : pD239 (AGPAAAAAL) andpD2359 (AGP-
ARAAAL) . The suggestion that pD2359 binds better than
pD239 has been confirmed by a solution phase competition
assay (data not shown) . In addition, the motif is consistent
with that of two known viral and tumor peptides, p18-I-10
and tum35B. The identification of this motif supported the
suggestion that a nonamer derivative of the undecamer
tum35B, tum35B-F9 would bind H-2D', and raises the pos-
sibility that this nonamer might be antigenic as well .
The structural constraints implied by the four motifresidues
were examined with the aid of 17 independent molecular
models of H-2Dsd/self-peptide/m02m complexes and two
similar models with the alanine-substituted motif peptides
(pD239 and pD2359) . We have described four different pat-
terns of interactions in the A pocket dependent on the bio-
chemical character of the side chain at position 1 of the pep-
tide . The differences in surface exposure of the side chain of
the first peptide residue and the complex interaction patterns
with the residues that line the A pocket dependent on the
side chain suggest that mAbs that bind in the region may
be able to discriminate different MHC/peptide combinations .
Indeed, this behavior has been observed for several anti-H-
2Dd (49) and anti-H-2Kb (50, 51) mAbs.
Whereas the A pocket exhibits a degree of plasticity to
accommodate side chains of different size and charge, the B
pocket of H-2Dd has strict requirements for acceptable
amino acids. The restriction to glycine-proline appears to be
more a configurational than a spatial constraint, evidenced
by the relatively large rms deviation at those positions. In-
deed glycine is restricted in its conformational freedom when
followed by proline. The 0/~ plot for glycine in glycine-
Rroline from nonhomologous structures determined to 2.5
A resolution or better shows a predominant clustering
around 0 = 180°, suggesting that glycine-proline nearly
always adopts an extended conformation (52) . Other class
I motifs that employ proline include H-2Ld (17), HLA-1335,
and HLA-1353 (40), which favor this residue at position 2 .
In the case of H-2Ld, modeling analysis suggested that the
B pocket was shallow and markedly spatially constrained .
The side chain of the fifth peptide residue is oriented to-
ward theD pocket, enabling salt bridging (through a basic
group) or hydrogen bonding (through threonine e.g ., pD34)
Figure 6 .
￿
Models of H-2Dd/peptide complexes. Three-dimensional molecular models of complexes of pD43 (A, E, and F); pD41 (B) ; pD42 (C) ;
and p18-1-10 (D) are shown . The region of theA pocket is shown in the same view for the four different models in A-D. The region of theD pocket
of pD43 is in (E) and that of the F pocket in (F) . Amino acid residues of H-213d from the al helix are in yellow and those from the C12 helix are
in red . The peptide residues are shown as N, blue; C, white; O, red; and polar H, light blue. Hydrogen bonds are shown as dotted lines. For clarity,
backbone atoms of H-213d residues are omitted, and only a selection of the residues is portrayed .
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￿
Molecular models of three H-2Dd bound peptides. The structures of models of an octamer pD35 (A), a nonamer pD43 (B), and a decamer
p18-1-10 (C) are shown as licorice models, with the NHZ-terminal residues to the left and the COOH-terminal residues to the right . Coloring is
by polarity as indicated in the legend to Fig . 5 .
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the positively charged residue to the interaction of the peptide
with theH chain is highlighted by the doubling of the number
of hydrogen bonds, the increase in van der Waals contacts
from 120 to 163 and in ion pairs in the models of the two
alanine-substituted motifpeptidespD239 and pD2359, which
differ solelyby the arginine residue at position 5 . The peptide-
dependent epitope induction data support the view that the
middle positively charged residue enhances the interaction
of the peptide with the H chain and can act as a fourth an-
choring position.
The D156 polymorphism is shared with H-2Dd by H-2Kk
and H-2Dk (53) . The peptide binding motif of H-2Kk in-
ferred from inspection of previously described viral and malarial
peptides is most likely glutamic acid at position 2 and isoleu-
cine at position 9 (54, 55) . There is no indication that these
peptides have a conserved central positively charged residue.
Unlike H-2Kk and H-2Dk, however, H-2Dd also has poly-
morphisms at W97 and W114 which form a ridge in the
floor of the groove . The side chain/side chain interactions
noted in MHC-bound H-2Dd-restricted peptides, namely
the interaction of 5 with 7, and 6 with 8, serve to kink the
otherwise fully extended peptide backbone into a bend per-
mitting the peptide to accommodate this ridge. H-2Kk and
H-2Dk both have arginine and glutamic acid at positions 97
and 114, respectively, which are capable not only of inter-
acting with each other, but also of interacting with bound
peptide. The W97/W114 pair in H-21)d may contribute to
a lower local dielectric constant than that expected for the
R97/E114 pair (in H-2Kk and H-2Dk), enhancing the elec-
trostatic interaction between the basic group at peptide posi-
tion 5 and D156 . Thus, the summed effects of D156, W97,
andW114 are likely to contribute to the advantage of a basic
residue at position 5 for H-2Dd peptides .
The positioning of the peptide by its interaction with res-
idue 156 of the H chain impacts on the conformational or
combinatorial interface necessary to effect signaling through
the TCR. This behavior is suggested by the failure of the
H-2Kb mutant bm1, which differs at positions 152 (E to A),
155 (R to Y), and 156 (L to Y), to present antigen to an
appropriately restricted effector T cell despite evidence that
it associates with the appropriate peptide (56, 57) . The anal-
ysis of the role of residue 156 in peptide presentation has been
refined by single-site mutational studies inHLA-A2 (58, 59) .
These studies showed that mutations at 156 could either en-
hance or abrogate functional peptide presentation depending
on the peptide .
In contrast to H-2Kb, the C pocket is not prominent in
the calculated surface representation of the binding cleft for
H-2Dd, and appears to play little if any role in the interac-
tions with peptide since there is no preference for hydrophobic
residues in the center of the H-2Dd/bound peptides . The E
pocket in H-2Dd is shallow as well, and its contribution to
peptide binding appears small. The deep hydrophobic F pocket,
like that of a number of otherMHC class I molecules exam-
ined (HLA-A2, H-W, and H-Ld), seems to play a major
role in anchoring the COOH terminus of H-21)d bound
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peptides. In otherMHC molecules, HLA-B27 (8) andHLA-
A3 (39), the F pocket appears capable of accommodating pep-
tides with positively charged COON-terminal residues as well
as hydrophobic ones.
Thus, the H-21)d bound peptides have several character-
istics that contribute to stable interactions with the MHC
molecule : defined length (8-10 residues), the above mentioned
motif, and the propensity for side chain/side chain interac-
tions . Each ofthese qualities may contribute not only to specific
interactions with H-2Dd itself, but may reflect entropic ad-
vantages. Short peptides clearly have less entropy than longer
ones, prolines severely limit entropy as compared to all other
amino acids by limiting the available torsion angles in the
backbone, and side chain/side chain interactions must also
contribute to a peptide with less potential disorder. Further
binding and structural analysis of more MHC-restricted pep-
tides and their substituted analogs can allow critical evalua-
tion of this possibility.
Molecular models made for decamer/H-2D1 , complexes,
designed to preserve the constraints of the motif residues,
illustrate the flexibility of the peptide backbone between an-
choring residues, particularly residues 6, 7, 8, and 9 . This
bend is consistent with crystallographic data on decamerHLA-
Aw68 complexes (60) The crystal structures ofH-2Kb com-
plexed with a nonamer or an octamer peptide (9, 11) describe
a similar kink in the peptide backbone between the A and
C pocket residues. In our analysis of nonamer peptides, residues
that are the most solvent accessible (residues 4, 6, and 8) are
also those with the most variability in amino acid selection .
These residues are likely to be epitopic (i .e., available forTCR
recognition), and the restricted accessibility of peptide res-
idue 7 may reflect the high frequency of interactions between
residues 5 and 7 . For the p18-I-10 decamer, because of a pre-
sumably larger kinked backbone between residues 5 and 10,
all the intervening amino acids are accessible to solvent, con-
sistent with the identification of residues 6, 7, and 8 as T
cell epitopic positions in the context of H-2Dd (42) .
Thus, the general rules that govern the interaction ofMHC
molecules with peptides continue to hold . Antigenic pep-
tides are a preferred length, so that both NH z - and 000H-
terminal groups can be bound, and they have a particular subset
ofresidues defined by hydrophobicity, size, polarity, or charge
to bind at anchor positions . These binding requirements then
allow the other, more solvent-exposed peptide residues to vary.
Our studies of H-2Dd bound peptides illustrate several
unique aspects of this developing theme : the exploitation of
four rather than one or two peptide residues for peptide
binding ; the plasticity of the molecular architecture in ac-
commodating the NHa-terminal peptide residue, and the
identification of a large number of intrapeptide interactions,
in this case likely to permit the peptide backbone to accom-
modate a ridge in the floor of the MHC molecule . As we
develop more precise understanding of the MHC/peptide in-
teraction and its structural causes and conformational conse-
quences, we may progress to a further characterization of a
deeper problem-how TCR interact with the MHC/pep-
tide complex .References
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